Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

65
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
65
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

830
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
830
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

704
Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
704

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and Management.

PharmacoEconomics - open·2025
Same author

Regulatory Aspects of Artificial Intelligence and Machine Learning.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2024
Same author

National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020.

JCO oncology practice·2021
Same author

Pharmacogenomics steps toward personalized medicine.

Personalized medicine·2018
Same author

Considerations for a business model for the effective integration of novel biomarkers into drug development.

Personalized medicine·2018
Same author

Personalized diagnostics: the struggle for position.

Personalized medicine·2018

Related Experiment Video

Updated: Apr 26, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

14.0K

Molecular diagnostics clinical utility strategy: a six-part framework.

Felix W Frueh1, Bruce Quinn

  • 1Opus Three, LLC, 9704 Medical Center Drive, Rockville, MD 20850, USA.

Expert Review of Molecular Diagnostics
|August 12, 2014
PubMed
Summary

The clinical utility of molecular diagnostic tests is crucial for regulatory approval and insurance coverage. This study clarifies its definition and proposes a framework to demonstrate a test's value proposition.

Keywords:
clinical utilitycombination diagnosticsguidelineshealth technology assessmentmolecular diagnosticspayersregulatory approval

More Related Videos

Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

6.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Related Experiment Videos

Last Updated: Apr 26, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

14.0K
Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

6.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Area of Science:

  • Health economics
  • Regulatory science
  • Molecular diagnostics

Background:

  • Clinical utility of molecular tests influences regulatory and payer decisions.
  • The definition of clinical utility remains a subject of debate.
  • Demonstrating value is key for test adoption.

Purpose of the Study:

  • To clarify the definition of clinical utility for molecular diagnostic tests.
  • To propose a framework for assessing and communicating test value.
  • To bridge communication gaps between test developers and evaluators.

Main Methods:

  • Literature review on clinical utility definitions.
  • Development of a six-part framework for value proposition assessment.
  • Analysis of regulatory and payer decision-making processes.

Main Results:

  • Clinical utility is defined by impact on clinical outcomes.
  • A structured framework can build confidence in a test's value.
  • The proposed framework aids regulatory and payer evaluations.

Conclusions:

  • The definition of clinical utility is straightforward and outcome-based.
  • A systematic approach is needed to prove the clinical value of diagnostic tests.
  • The proposed framework facilitates evidence generation for regulatory and reimbursement decisions.